Molecular tumor boards in pancreatic cancer with liver metastasis: A case report

Figure 1 Contrast-enhanced abdominal magnetic resonance imaging findings of hepatic metastases before and during systemic therapy. A: The baseline imaging demonstrates multiple heterogeneously enhancing hepatic metastases (the arrow indicates a confluent tumor mass); B: After treatment for 7 months, the number and size of the metastatic lesions decreased. The arrow-indicated confluent tumor mass is markedly reduced in size; C: After treatment for 9 months, the lesions further improved (indicated with arrow).